Todos Medical Ltd. (TOMDF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jun 30, 2025
Todos Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | 2012 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '22 Sep 30, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | 2012 - 2016 |
| 10.75 | 12.23 | 5.21 | - | - | - | Upgrade
| |
Revenue Growth (YoY) | -7.85% | 134.88% | - | - | - | - | Upgrade
|
Cost of Revenue | 6.27 | 7.85 | 3.82 | - | - | - | Upgrade
|
Gross Profit | 4.48 | 4.38 | 1.39 | - | - | - | Upgrade
|
Selling, General & Admin | 15.27 | 12.85 | 5.79 | 2.76 | 0.92 | 0.62 | Upgrade
|
Research & Development | 0.74 | 0.82 | 9.86 | 0.76 | 0.46 | 0.72 | Upgrade
|
Operating Expenses | 16.01 | 13.67 | 15.65 | 3.52 | 1.38 | 1.34 | Upgrade
|
Operating Income | -11.53 | -9.29 | -14.26 | -3.52 | -1.38 | -1.34 | Upgrade
|
Interest Expense | -21.4 | -28.61 | -13.37 | -0.96 | - | - | Upgrade
|
Earnings From Equity Investments | -0.16 | -1.66 | -1.2 | -2.97 | - | - | Upgrade
|
Currency Exchange Gain (Loss) | -3.41 | -2.57 | -0.67 | -0.06 | 0.05 | -0.07 | Upgrade
|
Other Non Operating Income (Expenses) | -0.57 | 0.84 | -3.65 | -2.89 | 0.88 | -1.27 | Upgrade
|
EBT Excluding Unusual Items | -37.07 | -41.28 | -33.15 | -10.39 | -0.46 | -2.68 | Upgrade
|
Impairment of Goodwill | -1.55 | -1.55 | - | - | - | - | Upgrade
|
Asset Writedown | -0.49 | -0.49 | - | - | - | - | Upgrade
|
Other Unusual Items | 0.27 | - | 3.38 | -1.42 | - | - | Upgrade
|
Pretax Income | -38.83 | -43.31 | -29.77 | -11.82 | -0.46 | -2.68 | Upgrade
|
Net Income | -38.77 | -43.31 | -29.77 | -11.82 | -0.46 | -2.68 | Upgrade
|
Preferred Dividends & Other Adjustments | - | - | - | - | - | -0.03 | Upgrade
|
Net Income to Common | -38.77 | -43.31 | -29.77 | -11.82 | -0.46 | -2.64 | Upgrade
|
Shares Outstanding (Basic) | 1,077 | 680 | 259 | 92 | 71 | 69 | Upgrade
|
Shares Outstanding (Diluted) | 1,077 | 680 | 259 | 92 | 71 | 69 | Upgrade
|
Shares Change (YoY) | 85.78% | 162.21% | 181.64% | 29.85% | 3.33% | 9.80% | Upgrade
|
EPS (Basic) | -0.04 | -0.06 | -0.11 | -0.13 | -0.01 | -0.04 | Upgrade
|
EPS (Diluted) | -0.04 | -0.06 | -0.11 | -0.13 | -0.01 | -0.04 | Upgrade
|
Free Cash Flow | -5.74 | -12.32 | -4.59 | -1.28 | -1.07 | -0.91 | Upgrade
|
Free Cash Flow Per Share | -0.01 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | Upgrade
|
Gross Margin | 41.66% | 35.84% | 26.68% | - | - | - | Upgrade
|
Operating Margin | -107.25% | -75.93% | -273.88% | - | - | - | Upgrade
|
Profit Margin | -360.67% | -354.16% | -571.79% | - | - | - | Upgrade
|
Free Cash Flow Margin | -53.36% | -100.74% | -88.11% | - | - | - | Upgrade
|
EBITDA | -10.74 | -8.52 | -14.17 | -3.49 | -1.35 | -1.31 | Upgrade
|
EBITDA Margin | -99.89% | -69.69% | -272.04% | - | - | - | Upgrade
|
D&A For EBITDA | 0.79 | 0.76 | 0.1 | 0.03 | 0.03 | 0.02 | Upgrade
|
EBIT | -11.53 | -9.29 | -14.26 | -3.52 | -1.38 | -1.34 | Upgrade
|
EBIT Margin | -107.25% | -75.93% | -273.88% | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.